In a study on 417 Caucasian patients with OC, another potential miR-409-3p recognition site polymorphism, MDM4 rs10900596 G > A, was related to an improved treatment response in ovarian cancer [116]. The gene discussed is MDM4; the disease is ovarian carcinoma.